Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Biocon Biologics' First-Ever Interchangeable Biosimilar Insulin Glargine, Co-Developed with Commercial Partner Viatris, Preferred on Express Scripts' Largest Formulary in US BIOCON LTD. - 532523 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018 BIOCON LTD. - 532523 - Shareholding for the Period Ended September 30, 2021
Biocon Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here Biocon Ltd - 532523 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 033321 Name of the Signatory :- Mayank VermaDesignation :- Company Secretary and Compliance Officer
Pandora Papers: 'Kunal Kashyap has no influence over Biocon-linked trust'
According to a company statement, the Deanstone Trust, which was mentioned as part of a leak of offshore tax haven files called the 'Pandora Papers,' was set up for philanthropic endeavours Biocon Ltd - 532523 - Board Meeting Intimation for Intimation For The Board Meeting And Trading Window Closure
BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2021 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, October 21, 2021, inter alia, to approve and take on record the un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2021, amongst other routine matters. The trading window for dealing in securities of the Company for all insiders, as defined under the Code of Conduct for Prevention of Insider Trading ('the Code') of the Company, has been closed from October 1, 2021 to October 23, 2021 (both days inclusive) in compliance with the provisions of the Code of the Company read with SEBI (Prohibition of Insider Trading) Regulations. BIOCON LTD. - 532523 - Board Meeting Intimation for Intimation For The Board Meeting And Trading Window Closure
BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2021 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, October 21, 2021, inter alia, to approve and take on record the un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2021, amongst other routine matters. The trading window for dealing in securities of the Company for all insiders, as defined under the Code of Conduct for Prevention of Insider Trading ('the Code') of the Company, has been closed from October 1, 2021 to October 23, 2021 (both days inclusive) in compliance with the provisions of the Code of the Company read with SEBI (Prohibition of Insider Trading) Regulations.
Kiran Mazumdar-Shaw says husband's offshore trust wrongly implicated
Kiran Mazumdar-Shaw on Monday said media reports on the 'Pandora Papers' leak have wrongly implicated her husband's offshore trust, and termed the organisation as "bonafide" and "legitimate". The industry veteran noted that both she and her husband are law abiding citizens. Anil Ambani, Vinod Adani, Jackie Shroff, Kiran Mazumdar-Shaw, Niira Radia, Sachin Tendulkar and Satish Sharma are among the many Indians who figure in the 'Pandora Papers' that have uncovered financial assets of leaders across the world. "Media stories reporting on Pandora Papers wrongly implicate my husband's offshore trust, which is a bonafide, legitimate trust and is managed by Independent Trustees. No Indian resident holds the key to the trust as alleged in these stories," Mazumdar-Shaw, the executive chairperson of biotechnology major Biocon, said in a tweet. Later, in a regulatory filing, she elaborated on the offshore trusts. "My husband, John Shaw is a UK national who from his foreign currency earnings Biocon Ltd - 532523 - Kiran Mazumdar Shaw'S Notification To Stock Exchanges
Please find attached the 'Kiran Mazumdar Shaw's Notification to Stock Exchanges with regard to John Shaw's Offshore Trust' The above-mentioned information will also be available on website of the Company at www.biocon.com. Request you to take the above intimation on record. BIOCON LTD. - 532523 - Kiran Mazumdar Shaw'S Notification To Stock Exchanges
Please find attached the 'Kiran Mazumdar Shaw's Notification to Stock Exchanges with regard to John Shaw's Offshore Trust' The above-mentioned information will also be available on website of the Company at www.biocon.com. Request you to take the above intimation on record.